| Chrysotile-induced cell transformation and transcriptional changes of c-myc oncogene in human embryo lung cells. | lung, |
| The helper virus envelope glycoprotein affects the disease specificity of a recombinant murine leukemia virus carrying a v-myc oncogene. | leukemia, |
| The prognostic importance of c-myc oncogene expression in head and neck melanoma. | skin,HNSC, |
| Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples. | breast, |
| Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. | lung, |
| Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. | colorectal, |
| Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. | colorectal, |
| [Clinical significance of c-myc oncogene amplification in primary hepatocellular carcinoma by interphase fluorescence in situ hybridization]. | liver, |
| N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth. | neuroblastoma, |
| Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene. | skin,sarcoma, |
| C-myc oncogene amplification in ductal carcinoma in situ of the breast. | breast, |
| Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors. | neuroblastoma, |
| In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression. | neuroblastoma, |
| Increased frequency of the S-allele of the L-myc oncogene in breast cancer. | breast, |
| The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma. | skin, |
| The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. | lymphoma, |
| Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas. | ovarian, |
| c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin s lymphoma. | lymphoma, |
| Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis. | skin, |
| c-myc coded oncoprotein for immunotargeting. Oropharyngeal and other tumors at S.N. Medical College, Agra, India. | laryngeal, |